[PDF][PDF] An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma

A Ooi, JC Wong, D Petillo, D Roossien… - Cancer cell, 2011 - cell.com
A Ooi, JC Wong, D Petillo, D Roossien, V Perrier-Trudova, D Whitten, BWH Min, MH Tan
Cancer cell, 2011cell.com
Fumarate hydratase (FH) mutation causes hereditary type 2 papillary renal cell carcinoma
(PRCC2). The main effect of FH mutation is fumarate accumulation. The current paradigm
posits that the main consequence of fumarate accumulation is HIF-α stabilization.
Paradoxically, FH mutation differs from other HIF-α stabilizing mutations, such as VHL and
SDH mutations, in its associated tumor types. We identified that fumarate can directly up-
regulate antioxidant response element (ARE)–controlled genes. We demonstrated that aldo …
Summary
Fumarate hydratase (FH) mutation causes hereditary type 2 papillary renal cell carcinoma (PRCC2). The main effect of FH mutation is fumarate accumulation. The current paradigm posits that the main consequence of fumarate accumulation is HIF-α stabilization. Paradoxically, FH mutation differs from other HIF-α stabilizing mutations, such as VHL and SDH mutations, in its associated tumor types. We identified that fumarate can directly up-regulate antioxidant response element (ARE)–controlled genes. We demonstrated that aldo-keto reductase family 1 member B10 (AKR1B10) is an ARE-controlled gene and is up-regulated upon FH knockdown as well as in FH null cell lines. AKR1B10 overexpression is also a prominent feature in both hereditary and sporadic PRCC2. This phenotype better explains the similarities between hereditary and sporadic PRCC2.
cell.com